Abvc Biopharma (ABVC) Return on Sales [ROS] (2010 - 2024)
Abvc Biopharma (ABVC) posted Return on Sales [ROS] of -22503.10% for FY2025, down 21579.76 percentage points from -923.34% in FY2024.
Powered by 
Analysis
Abvc Biopharma (ABVC) Return on Sales [ROS] (2010 - 2024) Analysis & Trends
Since FY2010, Abvc Biopharma has reported Return on Sales [ROS] for 11 years.
- Annual Return on Sales [ROS] shows a five-year change of -20742.23 percentage points (FY2020 to FY2025).
- The FY2025 figure stands as the lowest annual Return on Sales [ROS] since FY2018.
- Business Quant data shows ABVC's Return on Sales [ROS] at -923.34% in FY2024 (+3515.90 pp), -4439.24% in FY2023 (-2880.70 pp), -1558.54% in FY2022 (+1731.53 pp) and -3290.07% in FY2021 (-1529.20 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Abvc Biopharma | 26.03 Mn | 28.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -35,837.44% |
| Sep 30, 2024 | -77.66% |
| Jun 30, 2024 | -734.24% |
| Mar 31, 2024 | -235,539.83% |
| Dec 31, 2023 | -23,641.34% |
| Sep 30, 2023 | -13,566.31% |
| Jun 30, 2023 | -35,911.64% |
| Mar 31, 2023 | -1,486.05% |
| Dec 31, 2022 | -531.92% |
| Sep 30, 2022 | -8,790.94% |
| Jun 30, 2022 | -654.24% |
| Mar 31, 2022 | -24,235.08% |
| Dec 31, 2021 | -3,290.07% |
| Sep 30, 2021 | -1,990.48% |
| Jun 30, 2021 | -6,474.08% |
| Mar 31, 2021 | -476.06% |
| Dec 31, 2020 | -7,799.30% |
| Sep 30, 2020 | -1,116.17% |
| Jun 30, 2020 | -527.13% |
| Mar 31, 2020 | -1,486.78% |
API Access
Abvc Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();